BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 15910890)

  • 1. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
    Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
    Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
    Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
    J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.
    Astarita G; Di Giacomo B; Gaetani S; Oveisi F; Compton TR; Rivara S; Tarzia G; Mor M; Piomelli D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):563-70. PubMed ID: 16702440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.
    Fu J; Gaetani S; Oveisi F; Lo Verme J; Serrano A; Rodríguez De Fonseca F; Rosengarth A; Luecke H; Di Giacomo B; Tarzia G; Piomelli D
    Nature; 2003 Sep; 425(6953):90-3. PubMed ID: 12955147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid messenger OEA links dietary fat intake to satiety.
    Schwartz GJ; Fu J; Astarita G; Li X; Gaetani S; Campolongo P; Cuomo V; Piomelli D
    Cell Metab; 2008 Oct; 8(4):281-288. PubMed ID: 18840358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M
    Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
    Sihag J; Jones PJH
    Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
    Brun S; Carmona MC; Mampel T; Viñas O; Giralt M; Iglesias R; Villarroya F
    Diabetes; 1999 Jun; 48(6):1217-22. PubMed ID: 10342807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells.
    Martínez de Ubago M; García-Oya I; Pérez-Pérez A; Canfrán-Duque A; Quintana-Portillo R; Rodríguez de Fonseca F; González-Yanes C; Sánchez-Margalet V
    Biochim Biophys Acta; 2009 Aug; 1791(8):740-5. PubMed ID: 19345745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats.
    Li L; Li L; Chen L; Lin X; Xu Y; Ren J; Fu J; Qiu Y
    J Pharmacol Sci; 2015 Mar; 127(3):244-50. PubMed ID: 25837920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice.
    Newberry EP; Kennedy SM; Xie Y; Luo J; Crooke RM; Graham MJ; Fu J; Piomelli D; Davidson NO
    J Lipid Res; 2012 Apr; 53(4):744-54. PubMed ID: 22327204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endocannabinoids and their analogues in obesity and eating disorders.
    Gaetani S; Kaye WH; Cuomo V; Piomelli D
    Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction.
    Yang Y; Chen M; Georgeson KE; Harmon CM
    Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R235-41. PubMed ID: 16902188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.
    Kelly LJ; Vicario PP; Thompson GM; Candelore MR; Doebber TW; Ventre J; Wu MS; Meurer R; Forrest MJ; Conner MW; Cascieri MA; Moller DE
    Endocrinology; 1998 Dec; 139(12):4920-7. PubMed ID: 9832429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of food intake by oleoylethanolamide.
    Lo Verme J; Gaetani S; Fu J; Oveisi F; Burton K; Piomelli D
    Cell Mol Life Sci; 2005 Mar; 62(6):708-16. PubMed ID: 15770421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.